Previous reports showed that CD8+ T-cells prevailed over CD4+ T-cells in the tumor lesions derived from neuroblastoma patients, which meant that the CD4+/CD8+ ratio in tumors was lower than that in peripheral blood [20]. Here, CD4 is linked to neuroblastoma.